"Chemours Stock Plunges as CEO and CFO Suspended Amid Accounting Probe"
Chemours Company's stock is plummeting after suspending CEO Mark Newman and two other top executives, as well as delaying the release of its fourth quarter report for the second time in a month. The suspensions are reportedly related to accounting concerns and reports into the company's ethics hotline, prompting analysts to make downgrades and causing the stock to drop approximately 40% this year.